Delivery Order SPE2DB22D1106-SPE2DB24FFJA2

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order with a Firm Fixed Price of $3,178.36. The contract is for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product, to support the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 7, 2025 and was awarded on July 3, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,898.23 Firm Fixed Price Delivery Order is for the supply of VIGAMOX 0.5% eye drops (3ml) to support federal healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,109.20, is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 13, 2024. This award is not associated with a set-aside...
This federal contract award, valued at $3,748.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, with a completion date of February 12, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of VIGAMOX 0.5% eye drops 3ml to the Defense Logistics Agency (DLA). The $4,990.91 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of November 25, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,218.40 fixed-price delivery order is for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product used for medical care. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $7,587.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product. The delivery order has an ultimate completion date of August 13, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies for the provision of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,029.40 firm fixed-price delivery order is for the procurement of 4567416979 ! VIGAMOX 0.5% EYE DROPS 3ML, with a period of performance through March 3, 2025. The award is not associated with a set-aside program and represents an open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,204.48 firm fixed-price delivery order is for the supply of Vigamox 0.5% eye drops, a specialty pharmaceutical product. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,207.02 firm fixed-price delivery order is for the procurement of VIGAMOX 0.5% eye drops, a medication used to treat certain eye infections. The award has an ultimate completion date of October 31, 2024 and was issued on October 30, 2024. There was no set-aside designation used for this contract. AmerisourceBergen...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFJA2
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,549.44 firm-fixed-price delivery order is for the supply of 4565541162 VIGAMOX 0.5% eye drops (3 mL) to support government healthcare programs. The award has an ultimate completion date of August 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of medical commodities and prescription drugs to federal healthcare facilities and beneficiaries. This specific award was not set aside for a particular business category.

Generated 11/21/24, 9:24 AM